Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Charanjeet Kaur (New Delhi, India), Charanjeet Kaur, Balakrishnan Menon, Mohammad Yusuf Dar, Harsh Vardhan. Evaluation of protease-antiprotease imbalance in moderate COPD without antitrypsin deficiency. Eur Respir J 2015; 46: Suppl. 59, 3619

Member's Comments

No comment yet.

Related content which might interest you: The relationship of small airways disease to spirometry and emphysema in alpha-1 antitrypsin deficiency Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Lung function decline in COPD in relation to MMP-12 and surfactant protein A Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Genetic influences on lung function decline in AATD Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015 Lung function in never smoking patients with alpha1antitrypsin deficiency Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 Elastance bronchodilator response reflects asthma pathology Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Lung clearance index in alpha-1-antitrypsin deficiency - A follow up Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Decline in lung function in patients with alpha-1-antitrypsin deficiency and airflow obstruction Source: International Congress 2014 – Lung function testing: new findings and new approaches Year: 2014 Oxidative stress and systemic inflammation in different COPD phenotypes Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Elevated IL-17A in very severe COPD is localized to mast cells and correlates with lung function decline Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 The role of the frizzled-8 receptor in COPD with chronic mucus hypersecretion Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 Lung function decline in patients with severe alpha1-antitrypsin deficiency Source: International Congress 2014 – Respiratory function: quality and new technologies Year: 2014 Mapping of eosinophil and basophils in COPD lung tissues Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Lung function impairment in adult asthma increases the risk of systemic inflammation Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Evaluation of vitamin D levels in COPD and its correlation with disease severity and frequency of exacerbations Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 The relationship between systemic inflammation and vitamin D levels in COPD Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Relationship between endothelial dysfunction and GOLD stage in patients with COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 The influence of hyperinflation on body composition and cytokine profile in patients with COPD Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 The relationship between surfactant protein D and respiratory functions in COPD Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014